These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11449745)

  • 41. The effectiveness of health care cost management strategies: a review of the evidence.
    Fronstin P
    EBRI Issue Brief; 1994 Oct; (154):1-22. PubMed ID: 10137614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.
    French MT; Popovici I; Tapsell L
    J Subst Abuse Treat; 2008 Dec; 35(4):462-9. PubMed ID: 18294803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public sector managed care for substance abuse treatment: opportunities for health services research.
    McCarty D; Argeriou M; Denmead G; Dilonardo J
    J Behav Health Serv Res; 2001 May; 28(2):143-54. PubMed ID: 11338326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managed care and case management of substance abuse treatment.
    Woodward A
    NIDA Res Monogr; 1992; 127():34-53. PubMed ID: 1436002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Savings from a Medicaid carve-out for mental health and substance abuse services in Massachusetts.
    Frank RG; McGuire TG
    Psychiatr Serv; 1997 Sep; 48(9):1147-52. PubMed ID: 9285974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration and its discontents: substance abuse treatment in the Oregon Health Plan.
    Laws KE; Gabriel RM; McFarland BH
    Health Aff (Millwood); 2002; 21(4):284-9. PubMed ID: 12117142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substance abuse service utilization under managed care: HMOs versus carve-out plans.
    Stein B; Reardon E; Sturm R
    J Behav Health Serv Res; 1999 Nov; 26(4):451-6. PubMed ID: 10565105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An introduction to economic evaluation of health care.
    Cunningham SJ
    J Orthod; 2001 Sep; 28(3):246-50. PubMed ID: 11504904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic costs, cost-effectiveness, financing, and community-based drug treatment.
    NIDA Res Monogr; 1991; 113():1-211. PubMed ID: 1762633
    [No Abstract]   [Full Text] [Related]  

  • 51. Estimating cost in health economic analyses.
    Papatheofanis FJ
    IEEE Eng Med Biol Mag; 2003; 22(5):14-5. PubMed ID: 14699930
    [No Abstract]   [Full Text] [Related]  

  • 52. Benefit determination under managed care for substance abuse treatment clients.
    McNeese-Smith DK; Crook MW; Marinelli-Casey P; Williams L; Rawson R
    Care Manag J; 2001-2002 Winter; 3(2):55-62. PubMed ID: 12455215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Service utilization and costs of care for severely mentally ill clients in an intensive case management program.
    Quinlivan R; Hough R; Crowell A; Beach C; Hofstetter R; Kenworthy K
    Psychiatr Serv; 1995 Apr; 46(4):365-71. PubMed ID: 7788458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The administrative control system of substance abuse managed care.
    Sosin MR
    Health Serv Res; 2005 Feb; 40(1):157-76. PubMed ID: 15663707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Forecasting the cost of drug abuse treatment coverage in private health insurance.
    McGuire TG; Shatkin BF
    NIDA Res Monogr; 1991; 113():175-89. PubMed ID: 1762639
    [No Abstract]   [Full Text] [Related]  

  • 56. Direct contracts for substance abuse benefits.
    Bradman LH
    J Health Care Benefits; 1994; 3(6):8-11. PubMed ID: 10171895
    [No Abstract]   [Full Text] [Related]  

  • 57. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of managed care on substance abuse treatment services.
    Olmstead T; White WD; Sindelar J
    Health Serv Res; 2004 Apr; 39(2):319-43. PubMed ID: 15032957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mental health and substance abuse services in the era of health care reform.
    Boyer JF
    J Ambul Care Manage; 1993 Oct; 16(4):50-9. PubMed ID: 10171525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.